A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.
Market Scope
Trusted Partner of Industry and Medical Professionals for Market Data, Independent Perspective, & Objective Analysis
Latest Reports Latest News
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Physician Surveys
For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.
Complete a Survey
On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.
Benchmark Your Performance
Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.
View Market Insights & Analytics
Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.
Learn More Register Today
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 85
Metropolitan Areas Analyzed for Premium Opportunity
- 1056
Tables and Figures
- 6
Astigmatism Populations Presented per Metro
Latest Industry News & Trends
2/25/2020
GlaucomaOphthalmicPharmaPress Release
Glaucoma Drug Revenues Fall in 2019 Despite Debut of New Products
The revenue from major, branded glaucoma drugs fell 5.4 percent in 2019 from 2018’s total, despite the launches of four new proprietary drugs since 2017. Increased competition from generics weighed...
2/21/2020
CataractNewsletterOphthalmicSurgical
Company is Focused on Implementing Office-Based Cataract Surgery as Advanced as ASC Procedure
Proponents of office-based surgery (OBS) view it as an opportunity to reduce the financial burden of cataract surgery on Medicare and insurance groups, while simultaneously offering surgeons more c...
2/21/2020
GlaucomaMeetingNewsletterOphthalmic
Qlaris Bio Wins Perfect Pitch Award at Glaucoma 360
Qlaris Bio, Inc., raised its profile at the 2020 Glaucoma 360 meeting, winning the Perfect Pitch Award, chosen by meeting attendees as the startup in which they would be most willing to invest. Thu...
2/21/2020
BreakingMeetingOphthalmic
Coronavirus Outbreak Pushes APAO Congress in China Back to August
The Asia-Pacific Academy of Ophthalmology has postponed its 2020 congress in Xiamen, China, due to the COVID-19 coronavirus outbreak. The congress will now take place Aug. 5-9 at the same site, Xia...
2/21/2020
BreakingOphthalmicPharma
Alcon Gains FDA Approval of OTC Pataday Through Rx-to-OTC Switch Process
Alcon will launch two versions of nonprescription Pataday on March 2 in the US after gaining FDA approval Feb. 14. The company’s spinoff from Novartis in 2019 included the rights to switch specifie...
2/21/2020
AtlasCataractNewsletterOphthalmicSurgical
New Cataract Atlas Identifies Location of Premium IOLs and High-Volume Surgeons
The metro areas of New York, Los Angeles, Dallas, and Chicago account for 14 percent of the population over 60 in the US. However, on a per capita share basis, most of the metro areas in Florida st...
2/21/2020
GlaucomaNewsletterOphthalmicPharma
Glaucoma Drug Revenue Falls in 2019 Despite Debut of New Products
The revenue from major, branded glaucoma drugs fell 5.4 percent in 2019 from 2018’s total, despite the launches of four new proprietary drugs since 2017. Increased competition from generics weighed...
2/21/2020
BreakingEarningsIOLOphthalmic
Bausch Health Reports Revenue of $2.22 Billion in Q4-2019 and $8.60 Billion in 2019
Bausch Health reported Feb. 19 that Q4-2019 revenue totaled $2.22 billion, an increase of 5 percent over $2.12 billion in Q4-2018. Total revenue for 2019 was $8.60 billion, an increase of 3 percent...
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.